Insiders Johnson & Johnson

Stocks

JNJ

US4781601046

Pharmaceuticals

Market Closed - NYSE Other stock markets 23:00:02 11/06/2026 +03			After hours 03:00:00
238.33 ^USD	-0.07%		235.34	-1.25%

06-11	Global markets live: Oracle, Microsoft, SpaceX, ASML, Frasers…
06-11	A Rebound With Strings Attached

Insiders

02-19	Johnson & Johnson Insider Sold Shares Worth $21,767,827, According to a Recent SEC Filing	MT
02-19	Johnson & Johnson Insider Sold Shares Worth $15,109,759, According to a Recent SEC Filing	MT
01-29	Johnson & Johnson Insider Sold Shares Worth $22,122,893, According to a Recent SEC Filing	MT
21/10/25	Johnson & Johnson Insider Sold Shares Worth $4,185,793, According to a Recent SEC Filing	MT
14/10/25	J&J CFO Wolk on Orthopedics Spinoff, Earnings, Drug Pricing	MT
09/09/25	Johnson & Johnson Elects John Morikis to its Board of Directors and Audit Committee and Compensation & Benefits Committee	CI
09/09/25	Johnson & Johnson elects John Morikis to its board of directors	RE
08/09/25	Johnson & Johnson Insider Sold Shares Worth $10,040,883, According to a Recent SEC Filing	MT
26/08/25	Johnson & Johnson Insider Sold Shares Worth $22,548,655, According to a Recent SEC Filing	MT
19/08/25	Johnson & Johnson Insider Sold Shares Worth $2,975,571, According to a Recent SEC Filing	MT
18/07/25	Johnson & Johnson Insider Sold Shares Worth $3,129,830, According to a Recent SEC Filing	MT
11/06/25	Johnson & Johnson Appoints Daniel Pinto to the Board of Directors, Effective July 1, 2025	CI
30/04/25	Johnson & Johnson Announces Retirement of D. Adamczyk from the Board of Directors, May 31, 2025	CI
15/04/25	J&J Expects Tariffs to Cost Company $400 Million	MT
14/04/25	ProQR Appoints Dennis Hom as CFO, Cristina Lopez as CMO	MT
05/03/25	Johnson & Johnson Announces Jessica Moore as Group Chief Financial Officer, Innovative Medicine, Effective May 1, 2025	CI
27/02/25	Johnson & Johnson Insider Sold Shares Worth $1,160,994, According to a Recent SEC Filing	MT
12/02/25	Johnson & Johnson Insider Sold Shares Worth $2,002,878, According to a Recent SEC Filing	MT
13/01/25	J&J to Buy Intra-Cellular for About $14 Billion	MT
15/10/24	J&J CFO Wolk on Product Pipeline, Strategy, Talc Lawsuit	MT
11/10/24	Johnson & Johnson Unit Can Retain Insolvency Case in Texas	MT
12/09/24	J&J CFO Sees Value in Tech Partnerships	MT
12/09/24	How J&J's CFO Keeps His Footing on the 'Patent Cliff'	MT
10/09/24	Johnson & Johnson Announces the Retirement of D. S. Davis as Director and Committee Changes	CI
03/09/24	Johnson & Johnson Insider Sold Shares Worth $930,113, According to a Recent SEC Filing	MT